E908:F:F-Lyxor 1 - TecDAX UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 24.235

Change

+0.11 (+0.44)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.18 (-0.66%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.26 (-0.50%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.05B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.26 (-0.26%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 40.74B
0ZC:F Zscaler Inc

+4.02 (+2.61%)

USD 37.92B

ETFs Containing E908:F

F703:XETRA Lyxor Portfolio Strategy .. 0.00 % 0.00 %

+1.54 (+1.01%)

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.32% 17% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.32% 17% F 44% F
Trailing 12 Months  
Capital Gain 9.27% 36% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.27% 36% F 52% F
Trailing 5 Years  
Capital Gain 12.93% 39% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.93% 39% F 51% F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike